Membership and Growth - Total membership reached 275,300 as of January 1, 2026, reflecting a 30% Compound Annual Growth Rate (CAGR) since inception[16] - The company projects year-end 2026 membership to be in the range of 290,000 to 296,000[16,46] - From 2024 to Q3 2025, peers averaged 1% annual membership growth[36] - As of January 1, 2026, 80% of new members are new to MA, and 20% are MA plan switchers[47] - January 1 net Medicare Advantage enrollment growth in California was +23,800 (+84% YoY)[47] - January 1 net Medicare Advantage enrollment growth Ex-California was +41,500 (+23% YoY)[47] Financial Performance - The company's total revenue has grown from $127 million in 2014 to $3939 million in 2024[16] - The company raised YE adjusted EBITDA guidance from $48M to $94M at the midpoint from initial guidance to current guidance[52] - The company expects consensus adjusted EBITDA of $145M to be within FY 2026 guidance range[52] Quality and Cost Management - 100% of Alignment's members are in plans rated 4 stars or above, compared to 65% for the industry[40] - The company invests ~4% of medical expenses for at-risk members in employed clinical model[21] - The company has achieved superior growth while managing medical costs effectively, differentiating itself from peers who averaged a 1% annual membership growth and an annual increase in MBR of 160bps[36] Market Position - The company has less than 1% national market share and approximately 6% share in existing markets[53] - The MA market is projected to grow further over the next decade, with MA penetration reaching 58% in 2034[54]

Key Takeaways HUM offered Atlas Oncology's care model to MA members in TN and MS from the beginning of 2026.The model provides holistic cancer support with clinical care, counseling, and care coordination services.Integrated tools and real-time support aim to reduce ER visits and align care with patient goals.Humana Inc. (HUM) recently unveiled a tie-up with Atlas Oncology Partners in a bid to provide enhanced cancer care, particularly for Medicare beneficiaries. Starting Jan. 1, 2026, eligible Humana Medic ...

Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earnings and margin expansion.Powered by AI, Clover continues to bring industry-leading clinical quality to members, with ~97% of Clover’s January 1, 2026 membership in flagship PPO plan that is ranked #1 nationally on cor ...

Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026.Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earnings and margin expansion.Powered by AI, Clover continues to bring industry-leading clinical quality to members, with ~97% of Clover’s January 1, 2026 membership in flagship PPO plan that is ranked #1 nationally on cor ...

Core Insights - UnitedHealth Group is facing significant challenges, including a decline in stock value and a U.S. government probe into its Medicare billing practices, which has affected investor confidence [1][3][7] - Despite these challenges, the company has implemented measures to improve its operations and financial performance, reporting a 12% revenue growth in the latest quarter and raising its earnings forecast for the year [5][6] Financial Performance - UnitedHealth's shares experienced a 34% decline over the past year due to underestimated care costs and increased service usage [2] - The company has raised its full-year earnings forecast to $14.90 per share, up from $14.65, indicating a positive outlook for earnings growth [5] Management and Strategic Actions - New CEO Steve Hemsley has initiated an independent assessment of the company's processes and has taken steps to address operational challenges [4][9] - The company has exited certain plans, adjusted benefits, and increased the use of artificial intelligence to streamline operations [5] Market Position and Long-term Outlook - UnitedHealth is well-positioned for long-term growth due to its leadership in the health insurance market and its dual business model comprising UnitedHealthcare and Optum services [8] - The stock is currently trading at 17 times trailing 12-month earnings, which is considered reasonably priced given the recovery efforts and long-term growth potential [9][11]

Come win with BAD BEAT Investing. It is TIME. TRY BAD BEAT for 55% off the trial price, $199 marked down to $87. Why join?We have been following the UnitedHealth Group Incorporated ( UNH ) story now for about a year. 2025 was a whirlwind, for sure. We saw huge management shifts. We saw the company mis-model the expected usage and costs whenThe Pioneer Of Seeking Alpha's BAD BEAT Investing, Quad 7 Capital is a team of 7 analysts with a wide range of experience sharing investment opportunities for nearly 12 y ...

Come win with BAD BEAT Investing. It is TIME. TRY BAD BEAT for 55% off the trial price, $199 marked down to $87. Why join?We have been following the UnitedHealth Group Incorporated ( UNH ) story now for about a year. 2025 was a whirlwind, for sure. We saw huge management shifts. We saw the company mis-model the expected usage and costs whenThe Pioneer Of Seeking Alpha's BAD BEAT Investing, Quad 7 Capital is a team of 7 analysts with a wide range of experience sharing investment opportunities for nearly 12 y ...

UnitedHealth ( UNH ) was one of the worst performing financial stocks of 2025. Down nearly 35% for the year, it vastly underperformed the S&P 500, which eked out a solid gain for theAnalyst’s Disclosure:I/we have a beneficial long position in the shares of UNH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whos ...

JP Morgan Presentation January 2026 1 Today's Speakers 2 Pete Anevski Chief Executive Officer Melissa Cummings Chief Operating Officer Katie Higgins Chief Commercial Officer Mark Livingston Chief Financial Officer Safe Harbor Statement Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements co ...

BLOOMFIELD, Conn., Jan. 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2025 financial results on Thursday, February 5, 2026, and will host a conference call the same day. Fourth quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (Internation ...